25T7-NBOMe

A synthetic psychedelic compound

25T7-NBOMe
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

25T7-NBOMe is a synthetic psychedelic compound belonging to the NBOMe series. It is a derivative of the phenethylamine 2C-T-7, and is known for its potent hallucinogenic effects.

Chemical structure and properties

25T7-NBOMe is chemically classified as a phenethylamine and a substituted amphetamine. Its structure includes a 2,5-dimethoxyphenethylamine core with an isopropylthio group at the 4-position and a 2-methoxybenzyl group attached to the nitrogen atom. This modification is responsible for its high affinity for the 5-HT2A receptor, which is thought to mediate its psychedelic effects.

Pharmacology

25T7-NBOMe acts primarily as a potent agonist of the 5-HT2A receptor, similar to other compounds in the NBOMe series. This receptor is a subtype of the serotonin receptor and is heavily involved in the modulation of mood, perception, and cognition. The activation of this receptor by 25T7-NBOMe is believed to be responsible for its psychedelic effects, which can include altered visual and auditory perceptions, changes in thought patterns, and an altered sense of time.

Effects

The effects of 25T7-NBOMe are similar to those of other psychedelics, such as LSD and psilocybin. Users report intense visual hallucinations, euphoria, and a sense of connection with the universe. However, the compound is also associated with adverse effects, including anxiety, paranoia, and, in some cases, dangerous physiological reactions such as tachycardia and hypertension.

Legal status

The legal status of 25T7-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important for researchers and users to be aware of the legal implications of possessing or distributing this compound.

Safety and toxicity

The safety profile of 25T7-NBOMe is not well-established, and there have been reports of severe adverse reactions and fatalities associated with its use. The compound's potency and the variability in individual responses make it particularly risky. Users are advised to exercise caution and to be aware of the potential for overdose.

Related pages

• NBOMe series
• 2C-T-7
• Psychedelic drug
• Serotonin receptor

Gallery

• 
  Chemical structure of 25T7-NBOMe